Does RISANKIZUMAB-RZAA Cause Injection site nodule? 27 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Injection site nodule have been filed in association with RISANKIZUMAB-RZAA. This represents 0.0% of all adverse event reports for RISANKIZUMAB-RZAA.
27
Reports of Injection site nodule with RISANKIZUMAB-RZAA
0.0%
of all RISANKIZUMAB-RZAA reports
0
Deaths
3
Hospitalizations
How Dangerous Is Injection site nodule From RISANKIZUMAB-RZAA?
Of the 27 reports, 3 (11.1%) required hospitalization.
Is Injection site nodule Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Injection site nodule?
EXENATIDE (2,167)
HYDROXYPROGESTERONE CAPROATE (425)
ADALIMUMAB (364)
PALIPERIDONE (313)
DUPILUMAB (271)
BYDUREON (241)
ETANERCEPT (215)
CABOTEGRAVIR (178)
NALTREXONE (154)
CABOTEGRAVIR\RILPIVIRINE (153)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Injection site nodule Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA